AHA Comments on HHS on 340B Program Proposals

AHA comments on the 340B section of the Department of Health and Human Services’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.

Key Resources

Related Resources

Advisory
HRSA Finalizes 340B Administrative Dispute Resolution Process
Member
Letter/Comment
AHA Responds to Senate RFI on the SUSTAIN 340B Act Draft
Guides/Reports
The 340B Drug Pricing Program
Advisory
Senators Release 340B Discussion Draft & RFI
Member
AHA Center for Health Innovation Market Scan
Cost-Plus Drug Pricing Models Gain Momentum, but Will They Last?
Case Studies
Grady Health System | Georgia